Compare · CFX vs EVAC
CFX vs EVAC
Side-by-side comparison of Colfax Corporation (CFX) and EQV Ventures Acquisition Corp. II (EVAC): market cap, price performance, sector, and recent activity on the wire.
Summary
- CFX operates in Capital Goods, while EVAC operates in Industrials - the two are in different parts of the market.
- CFX carries a market cap of $6.33B.
- CFX has more recent analyst coverage (12 ratings vs 0 for EVAC).
- Company
- Colfax Corporation
- EQV Ventures Acquisition Corp. II
- Price
- $38.98-3.93%
- $10.12+0.35%
- Market cap
- $6.33B
- -
- 1M return
- -
- +0.35%
- 1Y return
- -
- +1.97%
- Industry
- Fluid Controls
- Fluid Controls
- Exchange
- NYSE
- NYSE
- IPO
- 2008
- 2025
- News (4w)
- 0
- 0
- Recent ratings
- 12
- 0
Colfax Corporation
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Annapolis Junction, Maryland.
Latest CFX
- SEC Form 4: Kleckner John sold $2,496 worth of shares (44 units at $56.73), decreasing direct ownership by 3% to 1,661 units (for tax liability)
- SEC Form 4: Perfall A Clayton was granted 432 shares, increasing direct ownership by 1% to 31,073 units
- SEC Form 4: Lalor Angela S was granted 319 shares, increasing direct ownership by 16% to 2,363 units
- SEC Form 4: Wienbar Sharon L was granted 410 shares, increasing direct ownership by 2% to 18,879 units
- Colfax Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 11-K filed by Colfax Corporation
- Colfax Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 4: Perfall A Clayton was granted 1,648 shares, increasing direct ownership by 6% to 30,641 units
- SEC Form 4: Kelly Liam was granted 1,648 shares, increasing direct ownership by 32% to 6,793 units
- SEC Form 4: Vinnakota Rajiv was granted 1,648 shares, increasing direct ownership by 16% to 11,901 units